• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亲和结合海藻酸钠生物材料控制 HGF 释放对后肢缺血模型血管生成和血液灌注的影响。

The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model.

机构信息

Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

出版信息

Biomaterials. 2010 Jun;31(16):4573-82. doi: 10.1016/j.biomaterials.2010.02.026. Epub 2010 Mar 5.

DOI:10.1016/j.biomaterials.2010.02.026
PMID:20206988
Abstract

Enhancing tissue self-repair through the use of active acellular biomaterials is one of the main goals of regenerative medicine. We now describe the features of an injectable alginate biomaterial designed to affinity-bind heparin-binding proteins and release them at a rate reflected by their association constant to alginate-sulfate. The interactions of hepatocyte growth factor (HGF) with alginate-sulfate resulted in factor protection from proteolysis, as shown by mass spectroscopy analysis after trypsin digestion. When the HGF/alginate-sulfate bioconjugate was incorporated into alginate hydrogel, HGF release was sustained by a factor of 3, as compared to the release rate from non-modified hydrogel. The released factor retained activity, as shown by its induction of ERK1/2 activation and affording cytoprotection in rat neonatal cardiomyocyte cultures. In vivo, an injectable form of the affinity-binding alginate system extended by 10-fold, as compared to a saline-treated group, retention of HGF in myocardial tissue when delivered immediately after myocardial infarction. In a severe murine hindlimb ischemia model, HGF delivery from the affinity-binding system improved tissue blood perfusion and induced mature blood vessel network formation. The therapeutic efficacy of the affinity-binding system, as well as its ease of delivery by injection, provides a proof-of-concept for the potential use of this bioactive biomaterial strategy in cardiovascular repair.

摘要

通过使用活性去细胞生物材料来增强组织的自我修复能力是再生医学的主要目标之一。我们现在描述了一种可注射藻酸盐生物材料的特性,该材料旨在亲和结合肝素结合蛋白,并根据其与藻酸盐硫酸盐的结合常数以一定的速率释放它们。 肝细胞生长因子(HGF)与藻酸盐硫酸盐的相互作用导致因子免受蛋白水解的保护,这可以通过胰蛋白酶消化后的质谱分析来证明。当 HGF/藻酸盐硫酸盐生物缀合物被掺入藻酸盐水凝胶中时,与非修饰水凝胶的释放速率相比,HGF 的释放速度延长了 3 倍。释放的因子保持活性,因为它可以诱导 ERK1/2 激活并为大鼠新生心肌细胞培养物提供细胞保护。在体内,与盐水处理组相比,亲和结合藻酸盐系统的可注射形式延长了 10 倍,在心肌梗死后立即给药时,心肌组织中 HGF 的保留。在严重的小鼠后肢缺血模型中,亲和结合系统中 HGF 的递送改善了组织血液灌注并诱导了成熟血管网络的形成。亲和结合系统的治疗效果及其通过注射进行递送的简便性为该生物活性生物材料策略在心血管修复中的潜在应用提供了概念验证。

相似文献

1
The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model.亲和结合海藻酸钠生物材料控制 HGF 释放对后肢缺血模型血管生成和血液灌注的影响。
Biomaterials. 2010 Jun;31(16):4573-82. doi: 10.1016/j.biomaterials.2010.02.026. Epub 2010 Mar 5.
2
The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction.通过可注射藻酸盐生物材料递呈 IGF-1 和 HGF 促进急性心肌梗死模型中心肌修复。
Biomaterials. 2011 Jan;32(2):565-78. doi: 10.1016/j.biomaterials.2010.08.097.
3
Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model.在大鼠后肢缺血模型中,由可注射壳聚糖/非抗凝血肝素水凝胶控释成纤维细胞生长因子-2诱导的治疗性血管生成
Wound Repair Regen. 2007 Jan-Feb;15(1):58-65. doi: 10.1111/j.1524-475X.2006.00185.x.
4
Injectable multifunctional microgel encapsulating outgrowth endothelial cells and growth factors for enhanced neovascularization.可注射多功能微凝胶包埋生长内皮细胞和生长因子以增强血管生成。
J Control Release. 2014 Aug 10;187:1-13. doi: 10.1016/j.jconrel.2014.05.010. Epub 2014 May 20.
5
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.人肝细胞生长因子基因诱导大鼠和兔后肢缺血模型的治疗性血管生成:外周动脉疾病治疗的临床前研究
Gene Ther. 2001 Feb;8(3):181-9. doi: 10.1038/sj.gt.3301379.
6
Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation.同时应用碱性成纤维细胞生长因子和肝细胞生长因子以增强血管形成。
J Vasc Surg. 2005 Jan;41(1):82-90. doi: 10.1016/j.jvs.2004.10.029.
7
Spontaneous Coassembly of Biologically Active Nanoparticles via Affinity Binding of Heparin-Binding Proteins to Alginate-Sulfate.通过肝素结合蛋白与硫酸藻酸盐的亲和结合实现生物活性纳米颗粒的自发共组装。
Nano Lett. 2016 Feb 10;16(2):883-8. doi: 10.1021/acs.nanolett.5b03598. Epub 2016 Jan 13.
8
Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.冠状动脉内注射原位形成的海藻酸盐水凝胶可逆转猪心肌梗死后的左心室重构。
J Am Coll Cardiol. 2009 Sep 8;54(11):1014-23. doi: 10.1016/j.jacc.2009.06.010.
9
Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat.注射用藻酸盐植入物对大鼠近期和陈旧性心肌梗死后心脏重塑及功能的影响。
Circulation. 2008 Mar 18;117(11):1388-96. doi: 10.1161/CIRCULATIONAHA.107.727420. Epub 2008 Mar 3.
10
Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.通过掺入控释碱性成纤维细胞生长因子微球增强三维多孔藻酸盐支架的血管化。
J Biomed Mater Res A. 2003 Jun 15;65(4):489-97. doi: 10.1002/jbm.a.10542.

引用本文的文献

1
Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy.基于水凝胶的平台用于癌症治疗中的阿霉素定点释放。
J Transl Med. 2024 Sep 30;22(1):879. doi: 10.1186/s12967-024-05490-3.
2
Technology for the formation of engineered microvascular network models and their biomedical applications.工程化微血管网络模型的构建技术及其生物医学应用。
Nano Converg. 2024 Mar 2;11(1):10. doi: 10.1186/s40580-024-00416-7.
3
Evaluation of Polysaccharide-Peptide Conjugates Containing the RGD Motif for Potential Use in Muscle Tissue Regeneration.
含RGD基序的多糖-肽缀合物在肌肉组织再生中潜在应用的评估
Materials (Basel). 2022 Sep 16;15(18):6432. doi: 10.3390/ma15186432.
4
Increasing angiogenic efficacy of conditioned medium using light stimulation of human adipose-derived stem cells.利用光刺激人脂肪来源干细胞来提高条件培养基的血管生成效力。
Commun Biol. 2022 Sep 13;5(1):957. doi: 10.1038/s42003-022-03838-3.
5
Advances for the treatment of lower extremity arterial disease associated with diabetes mellitus.糖尿病相关下肢动脉疾病的治疗进展
Front Mol Biosci. 2022 Aug 17;9:929718. doi: 10.3389/fmolb.2022.929718. eCollection 2022.
6
Construction and Evaluation of Small-Diameter Bioartificial Arteries Based on a Combined-Mold Technology.基于组合模具技术的小口径生物人工动脉的构建与评估
Polymers (Basel). 2022 Jul 29;14(15):3089. doi: 10.3390/polym14153089.
7
A Thermoresponsive Chitosan/β-Glycerophosphate Hydrogel for Minimally Invasive Treatment of Critical Limb Ischaemia.一种用于微创治疗严重肢体缺血的热响应性壳聚糖/β-甘油磷酸水凝胶。
Polymers (Basel). 2021 Oct 16;13(20):3568. doi: 10.3390/polym13203568.
8
Zinc-containing Mohs' paste affects blood flow and angiogenesis suppression.含锌的莫氏糊剂会影响血流和抑制血管生成。
Daru. 2021 Dec;29(2):321-328. doi: 10.1007/s40199-021-00409-5. Epub 2021 Aug 21.
9
Prevascularized Micro-/Nano-Sized Spheroid/Bead Aggregates for Vascular Tissue Engineering.用于血管组织工程的预血管化微/纳米级球体/微珠聚集体
Nanomicro Lett. 2021 Aug 18;13(1):182. doi: 10.1007/s40820-021-00697-1.
10
Therapeutic Biomaterial Approaches to Alleviate Chronic Limb Threatening Ischemia.缓解慢性肢体威胁性缺血的治疗性生物材料方法
Adv Sci (Weinh). 2021 Feb 8;8(7):2003119. doi: 10.1002/advs.202003119. eCollection 2021 Apr.